The consequences of epigenetic drugs in the treatment of AML
Why daratumumab is effective in multiple myeloma - results from the CASTOR trial
Is CLL curable today?
MRD negativity and its role as a predictor for CLL patient responses
An overview of 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias